SRZN Stock Analysis: Buy, Sell, or Hold?
SRZN - Surrozen, Inc. Common
$27.87
-0.57 (-2.00%)
▼
5d:
-0.46%
30d:
-2.35%
90d:
+23.32%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 08, 2026
Get Alerted When SRZN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SRZN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: SRZN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: SRZN is currently trading at $27.87, which is considered slightly high relative to its 30-day fair value range of $25.72 to $28.19.
Technical Outlook: Technically, SRZN is in a strong uptrend. Immediate support is located at $23.63, while resistance sits at $29.99.
Market Sentiment: SRZN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $38.75 (+39.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SRZN is in a strong uptrend. Immediate support is located at $23.63, while resistance sits at $29.99.
Market Sentiment: SRZN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $38.75 (+39.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$25.72 -
$28.19
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 39.0% below Wall St target ($38.75)
Fair Price Analysis
30-Day Fair Range
$25.72 -
$28.19
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$23.63
Resistance Level
$29.99
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.82
Wall Street Target
$38.75
(+39.0%)
Revenue Growth (YoY)
-19.4%
Share & Embed Analysis
Last updated: April 03, 2026 1:52 AM ET
Data refreshes hourly during market hours. Next update: 2:52 AM
Data refreshes hourly during market hours. Next update: 2:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRZN showing a specific setup today?
Insider Activity (6 Months)
20
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Tcg Crossover Gp Ii, Llc
BUY
1190 shares
2026-03-16
Tcg Crossover Gp Ii, Llc
BUY
35433 shares
2026-03-13
Tcg Crossover Gp Ii, Llc
BUY
12374 shares
2026-03-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 61 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 61 BUY |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$290 | 53 HOLD |
